Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4.

Name: Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4.
Author: Ohar, Jill

Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4. — المؤلف: Ohar, Jill — International journal of chronic obstructive pulmonary disease 20190729

المؤلف: Ohar, Jill
النشر: International journal of chronic obstructive pulmonary disease 20190729
الوصف: 27-37 p.
الموضوعات: Administration, Inhalation؛ Adult؛ Age Factors؛ Aged؛ Aged, 80 and over؛ Bronchodilator Agents؛ Clinical Trials, Phase III as Topic؛ Drug Administration Schedule